Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (201-210 of 470) with videos related to

Pageof 47
Sort By:
Biochemical and Biophysical Research Communications|September 8, 2004
Cloning and characterization of the promoter of human Wnt inhibitory factor-1Noemi Reguart, Biao He, Zhidong Xu, et al.
Anticancer Research|August 9, 2015
Neoadjuvant Chemoradiotherapy Treatment for a Classic Biphasic Pulmonary Blastoma with High PD-L1 ExpressionJoaquim Bosch-Barrera, Francia Holguin, Xavier Baldó, et al.
Cancer Investigation|September 18, 2008
PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistanceMariacarmela Santarpia, Giuseppe Altavilla, Mireia Margeli, et al.
Clinical & Experimental Metastasis|December 1, 2012
Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of intrathoracic lymph node metastases from extrathoracic malignanciesJose Sanz-Santos, Beatriz Cirauqui, Estefania Sanchez, et al.
Translational Lung Cancer Research|March 26, 2015
A critical question for cancer therapy: what new targets exist?Rafael Rosell, Niki Karachaliou, Jordi Codony, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 12, 2026
Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategiesAnisha Jain, Rafael Rosell, Chandan Dharmashekara, et al.
Human Molecular Genetics|August 20, 2004
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancerMiquel Taron, Rafael Rosell, Enriqueta Felip, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 6, 2019
Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysisLong Jiang, Mari Mino-Kenudson, Anja C Roden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinomaDan J Raz, M Roshni Ray, Jae Y Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancerGlen J Weiss, Corey Langer, Rafael Rosell, et al.
Pageof 47

Showing results (201-210 of 470) with videos related to

Sort By:
Pageof 47
Biochemical and Biophysical Research Communications|September 8, 2004
Cloning and characterization of the promoter of human Wnt inhibitory factor-1Noemi Reguart, Biao He, Zhidong Xu, et al.
Anticancer Research|August 9, 2015
Neoadjuvant Chemoradiotherapy Treatment for a Classic Biphasic Pulmonary Blastoma with High PD-L1 ExpressionJoaquim Bosch-Barrera, Francia Holguin, Xavier Baldó, et al.
Cancer Investigation|September 18, 2008
PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistanceMariacarmela Santarpia, Giuseppe Altavilla, Mireia Margeli, et al.
Clinical & Experimental Metastasis|December 1, 2012
Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of intrathoracic lymph node metastases from extrathoracic malignanciesJose Sanz-Santos, Beatriz Cirauqui, Estefania Sanchez, et al.
Translational Lung Cancer Research|March 26, 2015
A critical question for cancer therapy: what new targets exist?Rafael Rosell, Niki Karachaliou, Jordi Codony, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 12, 2026
Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategiesAnisha Jain, Rafael Rosell, Chandan Dharmashekara, et al.
Human Molecular Genetics|August 20, 2004
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancerMiquel Taron, Rafael Rosell, Enriqueta Felip, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 6, 2019
Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysisLong Jiang, Mari Mino-Kenudson, Anja C Roden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinomaDan J Raz, M Roshni Ray, Jae Y Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancerGlen J Weiss, Corey Langer, Rafael Rosell, et al.
Pageof 47